MedTrace Logo

Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens

NCT05821582 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-10-12

No results posted yet for this study

Summary

The primary objective of the study is to determine whether there is a correlation between the intestinal side effects of chemotherapy treatment and the expression/activity profiles of glucuronidase enzymes in the stool microbiome of the target patient population.

Conditions

Interventions

OTHER

Stool Collection and Survey Completion

Participants will have 2 scheduled at-home stool self-collections at the time points specified in section 4.0 and complete a questionnaire by telephone contact. The biospecimens collected from participants on this study are stool samples.

Sponsors & Collaborators

  • Sanguine Biosciences

    lead INDUSTRY

Principal Investigators

  • Andrew C Frisina, M.S. · Sanguine Biosciences

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2023-10-05
Completion
2023-10-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05821582 on ClinicalTrials.gov